首页 / 院系成果 / 成果详情页

DNMT1 mediates metabolic reprogramming induced by Epstein-Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma  期刊论文  

  • 编号:
    ea51fa12-ce7a-4866-ac86-2619f3f64175
  • 作者:
    Luo, Xiangjian[1,2,3];Hong, Liping[1,2,3];Cheng, Can[1,2,3];Li, Namei[1,2,3];Zhao, Xu[1,2,3];Shi, Feng[1,2,3];Liu, Jikai[4];Fan, Jia(樊嘉)[5]Zhou, Jian(周俭)[5]Bode, Ann M.[6];Cao, Ya[1,2,3,7,8];
  • 语种:
    英文
  • 期刊:
    CELL DEATH & DISEASE ISSN:2041-4889 2018 年 9 卷 ; MAY 23
  • 收录:
  • 摘要:

    Cancer cells frequently adapt fundamentally altered metabolism to support tumorigenicity and malignancy. Epigenetic and metabolic networks are closely interactive, in which DNA methyltransferases (DNMTs) play important roles. Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (EBV-LMP1) is closely associated with nasopharyngeal carcinoma (NPC) pathogenesis because it can trigger multiple cell signaling pathways that promote cell transformation, proliferation, immune escape, invasiveness, epigenetic modification, and metabolic reprogramming. Our current findings reveal for the first time that LMP1 not only upregulates DNMT1 expression and activity, but also promotes its mitochondrial translocation. This induces epigenetic silencing of pten and activation of AKT signaling as well as hypermethylation of the mtDNA D-loop region and downregulation of oxidative phosphorylation (OXPHOS) complexes, consequently, leading to metabolic reprogramming in NPC. Furthermore, we demonstrate that grifolin, a natural farnesyl phenolic compound originated from higher fungi, is able to attenuate glycolytic flux and recover mitochondrial OXPHOS function by inhibiting DNMT1 expression and activity as well as its mitochondrial retention in NPC cells. Therefore, our work establishes a mechanistic connection between epigenetics and metabolism in EBV-positive NPC and provides further evidence for pathological classification based on CpG island methylator phenotype (CIMP) in EBV-associated malignancies. In addition, grifolin might be a promising lead compound in the intervention of high-CIMP tumor types. The availability of this natural product could hamper tumor cell metabolic reprogramming by targeting DNMT1.

  • 推荐引用方式
    GB/T 7714:
    Luo Xiangjian,Hong Liping,Cheng Can, et al. DNMT1 mediates metabolic reprogramming induced by Epstein-Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma [J].CELL DEATH & DISEASE,2018,9.
  • APA:
    Luo Xiangjian,Hong Liping,Cheng Can,Li Namei,&Cao Ya.(2018).DNMT1 mediates metabolic reprogramming induced by Epstein-Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma .CELL DEATH & DISEASE,9.
  • MLA:
    Luo Xiangjian, et al. "DNMT1 mediates metabolic reprogramming induced by Epstein-Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma" .CELL DEATH & DISEASE 9(2018).
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:7 下载次数:0
浏览次数:7
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部